Dow Down 1.40% Nasdaq Down 1.59%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.09 0.10(2.39%) Oct 1, 4:00PM EDT
Prev Close:4.19
Open:4.21
Bid:0.01 x 100
Ask:5.15 x 4200
1y Target Est:7.00
Beta:-2.28
Earnings Date:Oct 27 - Nov 6 (Est.)
Day's Range:3.98 - 4.21
52wk Range:3.82 - 7.97
Volume:6,348,189
Avg Vol (3m):5,036,150
Market Cap:899.13M
P/E (ttm):N/A
EPS (ttm):-0.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 2.39%899.13M
GSK110.25B
OREX495.04M
RHHBY249.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback